| 101/163 | US=64 / Câncer Dai Y, Grant S. CDK inhibitors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 331-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4. INIBIDORES DE CDK NO MIELOMA MULTIPLO; PROGRESSAO DO CICLO CELULAR; QUINASES DEPENDENTES DE CICLINA |
| 102/163 | US=64 / Câncer Jiménez-Zepeda VH, Stewart AK. Fibroblast growth, factor receptor 3 and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 365-78. (Comtemporary Hematology) ISBN 978-1-934115-82-4. CRESCIMENTO DE FIBROBLASTOS; RECEPTOR DO FACTOR DE 3; MIELOMA MULTIPLO; TRANSLOCACOES CROMOSSOMICAS |
| 103/163 | US=64 / Câncer Hideshima T. Histone deacetylase inhibitors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 379-92. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 104/163 | US=64 / Câncer Mollinedo F. Death receptors in multiple myeloma and therapeutic opportunities. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 393-419. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 105/163 | US=64 / Câncer Chauhan D, Singh A, Anderson K. Proteasome inhibitors as therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 421-32. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TERAPIA EM MIELOMA MULTIPLO. INIBIDORES DE PROTEASSOMA; HOMEOSTASE CELULAR NORMAL; AGENTES ANTICANCERIGENOS. INIBIDORES DE PROTEASSOMA |
| 106/163 | US=64 / Câncer Mark TM, Pearse RN. Pathophysiology of bone disease in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 435-54. (Comtemporary Hematology) ISBN 978-1-934115-82-4. DOENCA OSSEA DO MIELOMA MULTIPLO. FISIOPATOLOGIA; MIELOMA MULTIPLO; MALIGNIDADE DE CELULAS PLASMATICAS; CRESCIMENTO DA MEDULA OSSEA |
| 107/163 | US=64 / Câncer Sloan MJ, Raje N. Anemia and erythropoietic growth factors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 455-68. (Comtemporary Hematology) ISBN 978-1-934115-82-4. ANEMIA; ERITROPOIESE EM MIELOMA MULTIPLO. FATORES DE CRESCIMENTO |
| 108/163 | US=64 / Câncer Durie BGM. The role of anatomic and functional imaging in myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 491-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4. PAPEL DA IMAGEM ANATOMICA EM MIELOMA; PAPEL DA IMAGEM FUNCIONAL EM MIELOMA |
| 109/163 | US=64 / Câncer Ailawadhi S, Chanan-Khan A. Management of multiple myeloma patients with renal dysfunction. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 499-516. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 110/163 | US=69 / Câncer Zhou Y, Alexanian R, Wang M. Targeted therapy in multiple myeloma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 213-36. ISBN 978-1-60327-423-4. TERAPIA-ALVO; MIELOMA MULTIPLO; PATOGENESE MOLECULAR; MICROAMBIENTE |
| 111/163 | US=64 / Câncer Dhodapkar MV. Immunobiology and immunotherapy of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 167-202. (Comtemporary Hematology) ISBN 978-1-934115-82-4. IMUNOLOBIOLOGIA DO MIELOMA MULTIPLO; IMUNOTERAPIA DO MIELOMA MULTIPLO |
| 112/163 | US=84-A / Biol/Mol Yasui H, Hideshima T, Anderson KC. Transformig growth factor-B in developing and advanced cancers: inhibition of TGF-B signaling in multiple myeloma and its bone marrow microenvironment. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 219-27. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; IL-6; VEGF; TGF-B RECEPTOR TIPO I; TBRI; MIELOMA MULTIPLO; MICROAMBIENTE DA MEDULA OSSEA; FATOR TRANSFORMADOR DE CRESCIMENTO; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDOR DE QUINASE SD-208 |
| 113/163 | US=84-A / Biol/Mol Hsu FJ, Teicher BA, McPherson JM. Development of inhibitors of transforming growth factor-B signaling for therapy: rationale for anti-TGF-B antibody therapy in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 757-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; IMUNOSSUPRESSAO; METASTASE OSSEA; CARCINOMA DE CELULAS RENAIS; MELANOMA; CANCER DE MAMA; HORMONAL DO CANCER DA PROSTATA REFRATARIOS; CANCER DE PANCREAS; MIELOMA MULTIPLO; LINFOMA DE NAO-HOGGKIN; BIOMARCADORES |
| 114/163 | US=86 / Biol/Mol Chauhan D, Hideshima T, Anderson KC. Targeting proteasomes as therapy in multiple myeloma. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 251-60. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. PROTEOSOMAS; SEGMENTACAO; TERAPIA; MIELOMA MULTIPLO; APOPTOSE; RESISTENCIA A DROGA; BORTEZOMIBE |
| 115/163 | US=111-A / Câncer Gribben JG. Management of haematological malignancies. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 1392-409. ISBN 978-0-470-01852-1. CANCER. TERAPIA; DOENCAS MALIGNAS HEMATOLOGICAS; LEUCEMIA AGUDA; LEUCEMIA LINFOBLASTICA AGUDA; LEUCEMIA LINFOCITICA CRONICA; LINFOMA NAO HODGKIN; LINFOMA DE CELULAS B; LINFOMA HODGKIN; MIELOMA MULTIPLO; GAMOPATIA MONOCLONAL |
| 116/163 | US=2 / Ortopedia Siemionow K, Lieberman IH. Vertebral augmentation and radiosurgery in the treatment of osteolytic vertebral fractures. In: Gunzburg R, Szpalski M, Aebi M. Vertebral tumors. Philadelphia: J B Lippincott, 2007. p. 157-69. ISBN 978-0-7817-8867-0. FRATURAS VERTEBRAIS OSTEOLITICAS. TERAPIA; AUMENTO VERTEBRAL; RADIOCIRURGIA; BIOMECANICA; METASTASE; MIELOMA MULTIPLA |
| 117/163 | US=71 / Câncer Chiari AP, Ribeiro RA, Guimarães RC, Oliveira VA, Stephani SD, Sales RMD, Lima VS, Andrade CJC, Lima GPF. Cuidados suportivos: uso clínico dos bisfosfonatos. In: Sociedade Brasileira de Oncologia Clínica. Manuais de condutas da Sociedade Brasileira de Oncologia Clínica. Belo Horizonte: SBOC, 2007. p. 253-60. BISFOSFONATOS. USO TERAPEUTICO; MIELOMA MULTIPLO; CANCER DE PROSTATA; CANCER DE MAMA; BISFOSFONATOS. COMPLICACOES |
| 118/163 | US=49 / Câncer Jernberg-Wiklund H, Nilsson K. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I). In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 139-65. ISBN 978-0-12-006697-1. MIELOMA MULTIPLO HUMANO; INSULIN-LIKE GROWTH FACTOR I; IGF-I |
| 119/163 | US=53 / Cab/Pesc Garrity JA, Henderson JW. Hematopoietic tumors. In: ___. Henderson's orbital tumors. 4th. Philadelphia: Lippincott Williams & Wilkins, 2007. p. 245-66. ISBN 0-7817-3869-5. TUMORES ORBITAIS; TUMORES HEMATOPOIETICOS; NEOPLASMAS DE CELULAS-B MADURO; LINFOMA NAO HODGKIN; LINFOMA DE BURKITT; LINFOMA EXTRANODAL DE CELULA B NA ZONA MARGINAL; HIPERPLASIA LINFOIDE; NEOPLASIAS DE CELULAS PLASMATICAS; PLASMOCITOMA SOLITARIA DO OSSO ORBITAL; PLASMOCITOMA EXTRAOSSEA; MIELOMA DAS CELULAS PLASMATICAS; AMILOIDOSE; LINFOMA HODGKIN; SARCOMA MIELOIDE |
| 120/163 | US=77-J / Câncer Nakagawa SA, Chung WT. Câncer ósseo e metastático. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 501-7. ISBN 8-5866523-7-0. CANCER OSSEO; TUMORES MUSCULOESQUELETICOS; OSTEOSSARCOMA; TUMOR DE EWING; MIELOMA MULTIPLO; METASTASE OSSEA; CONDROSSARCOMA |